|
ZSCAN21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.52120000005163E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.293580E-02 |
| Normal-vs-Stage2 |
1.599650E-03 |
| Normal-vs-Stage3 |
2.575499999935E-07 |
| Normal-vs-Stage4 |
3.20129999997754E-06 |
| Stage1-vs-Stage2 |
1.039560E-01 |
| Stage1-vs-Stage3 |
2.601000E-03 |
| Stage1-vs-Stage4 |
7.602200E-03 |
| Stage2-vs-Stage3 |
5.691800E-01 |
| Stage2-vs-Stage4 |
7.430000E-01 |
| Stage3-vs-Stage4 |
7.733400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63699999999878E-06 |
| Normal-vs-AfricanAmerican |
2.250600E-01 |
| Normal-vs-Asian |
7.145000E-01 |
| Caucasian-vs-AfricanAmerican |
8.431900E-02 |
| Caucasian-vs-Asian |
4.179200E-01 |
| AfricanAmerican-vs-Asian |
9.010800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59519999934454E-08 |
| Normal-vs-Female |
8.148100E-02 |
| Male-vs-Female |
1.840260E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.764900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.207000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.10019999999922E-05 |
| Normal-vs-Age(81-100Yrs) |
2.326800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.801000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.451600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.852400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.117400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.844600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.867000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.978000E-01 |
| Normal-vs-Grade 2 |
8.476000E-03 |
| Normal-vs-Grade 3 |
2.51880000001758E-06 |
| Normal-vs-Grade 4 |
9.68159996617146E-09 |
| Grade 1-vs-Grade 2 |
1.784630E-01 |
| Grade 1-vs-Grade 3 |
1.877790E-02 |
| Grade 1-vs-Grade 4 |
4.755900E-04 |
| Grade 2-vs-Grade 3 |
6.179800E-02 |
| Grade 2-vs-Grade 4 |
3.621600E-04 |
| Grade 3-vs-Grade 4 |
4.134000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.096400E-01 |
| Normal-vs-ccB subtype |
2.20845564058436E-12 |
| ccA subtype-vs-ccB subtype |
7.73210384608092E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47009999999803E-05 |
| Normal-vs-N1 |
1.41899999994699E-06 |
| N0-vs-N1 |
7.956200E-02 |
|
|
